10:00 AM
-
50 minsThe latest HSBC Venture Healthcare report shows increased levels of investment in 2024 with Seed and Series A total investment doubling and investment in preclinical deals already surpassing 2023. The ...
11:00 AM
-
50 minsAdvances in neurodegenerative science have pointed to new paths in the development of medicines that have the potential to dramatically improve patient quality of life. These advances are contributing ...
1:00 PM
-
50 minsIn a highly competitive landscape, a compelling narrative that highlights your unique value proposition is essential for attracting investor attention, particularly in high-interest indications like o ...
2:00 PM
-
90 minsBIO has collaborated with a set of programs focused on entrepreneur development to curate an afternoon of seed-stage company pitches from promising new companies ready to pursue investment or partneri ...
-
90 mins
- Gene/Cell Therapy
-
90 mins
- Gene/Cell Therapy
-
90 minsSpeakers
-
90 mins
- Platform for Therapeutics
-
90 mins
-
90 mins
- CNS/Neurological
-
90 mins
- CNS/Neurological
3:45 PM
-
95 minsBIO has collaborated with a set of programs focused on entrepreneur development to curate an afternoon of seed-stage company pitches from promising new companies ready to pursue investment or partneri ...
-
95 mins
- Oncology
-
95 mins
- Oncology
-
95 mins
- Oncology
-
95 mins
-
95 mins
-
95 mins
- Oncology
-
95 mins
- Oncology
-
95 mins
- Oncology
9:00 AM
-
50 minsAPAC markets are among the largest and fastest growing in the world, with a legacy of successful international collaborations within drug development and direct investment in biotechs. However, post-p ...
10:00 AM
-
50 minsWith oncology continuing to bear ripe opportunities for investors, new modalities such as antibody-drug conjugates (ADCs) and radiopharmaceuticals are garnering significant interest. These approaches ...Speakers
11:00 AM
-
50 minsAs the newest iterations of AlphaFold’s molecular modeling tool and ChatGPT’s language and coding models, among several others, lower the barriers for implementing AI applications at biotechs, the cha ...
.jpeg)
2:00 PM
-
50 minsWith the first pricing negotiation results of the Inflation Reduction Act now public, analysts will be diagnosing trends for commercial companies and the implications for their pipelines. Those pipeli ...
.jpg)
3:00 PM
-
50 minsWhile the rate of IPOs this year is slightly increased versus 2023, the market is still much less active since 2021 and expecting Q3 interest rate cuts to spark additional investor support. This sessi ...
)
){kind=logo}
)
)
){kind=logo}
)